Antabio's Angel Round

Antabio raised a round of funding on January 12, 2012. Investors include Christophe Ricard.

Antabio is a biopharmaceutical company developing novel antibacterial resistance-breakers to treat drug-resistant infections in areas of highest unmet medical need.…

Articles about Antabio's Angel Round: